A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD
T. Sjåheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), M. Durheim (Oslo, Norway)
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Disease area: Interstitial lung diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Sjåheim (Oslo, Norway), A. Hoffman-Vold (Oslo, Norway), T. Eagan (Bergen, Norway), A. Hovden (Asker, Norway), M. Lund (Oslo, Norway), G. Bjerke (Lørenskog, Norway), T. Jonassen (Bergen, Norway), O. Johansen (Asker, Norway), M. Durheim (Oslo, Norway). A comparison of heath-related quality of life in IPF and systemic sclerosis-related ILD. 4735
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: